Related Experiment Video
Updated: Mar 16, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Treatment of HEV Infection in Patients with a Solid-Organ Transplant and Chronic Hepatitis
Nassim Kamar1,2,3, Sébastien Lhomme4,5,6, Florence Abravanel7,8,9
1Department of Nephrology and Organ Transplantation, CHU Rangueil, Toulouse 31059, France. kamar.n@chu-toulouse.fr.
Abstract:
Hepatitis E virus (HEV) infection can cause hepatic and extra-hepatic manifestations. Treatment of HEV infection has been thoroughly studied in solid-organ-transplant patients who have developed a chronic HEV infection. In this review, we report on our current knowledge regarding treatment of HEV infection.
More Related Videos
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant III: Nursing Management
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Retrovirus Life Cycles
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...

